Company: OSRH
Filing Date: 2025-01-29
Form Type: S-4/A
Source: 0001213900-25-007923
Chunk: 410

Company: OSR Holdings, Inc.
Filing Date: 2025-01-29
Form: S-4/A
Chunk 410
---
201917030262 a |     | 16/02/2038 |     | under examination |
| JP      |     | PCT  |     | 16/02/2018  |     |       2019-544614 |     |            |     |              |     |                |     | 16/02/2038 |     | under examination |
| US      |     | PCT  |     | 16/02/2018  |     |        16/486,425 |     | 20/04/2021 |     | 10980868B2   |     | 2020038496 A   |     | 16/02/2038 |     | granted           |

VXM10 — PD-L1 (8)
WO 2018/167290, Novel PD-L1 targeting DNA vaccine for cancer immunotherapy

| Country 
 Code    |     | Type |     | Filing date |     |        Filing no. |     | Grant Date |     | Grant no. |     |      Publ. No. |     | Expiry     |     | Status            |
| WO      |     | PCT  |     | 16/02/2018  |     | PCT/EP2018/056721 |     |            |     |           |     | WO 2018/167290 |     | —          |     |                   |
| CN      |     | PCT  |     | 16/02/2018  |     |    201880018761.6 |     |            |     |           |     |      110430893 |     | 16/02/2038 |     | under examination |
| EP      |     | PCT  |     | 16/02/2018  |     |          18710879 |     |            |     |           |     |      3 595 704 |     | 16/02/2038 |     | under examination |
| JP      |     | PCT  |     | 16/02/2018  |     |       2019-550795 |     |            |     |           |     |    2020-511139 |     | 16/02/2038 |     | under examination |

VXM01 in combination with an antibiotic (9)
WO 2021/144254, Salmonella